Demystifying SIBO with Dr Jason Hawrelak
This 3-part webinar series, presented by Dr Jason Hawrelak, will discuss many of the controversies in the diagnosis and treatment of SIBO, as well as update you on recent research in this area. By the end of this course, you will have a refreshed understanding of SIBO and the practical applications of testing and therapeutic strategies from one of the leaders in this field.
Small Intestinal Bacterial Overgrowth (SIBO) is a relatively new and poorly characterised diagnosis. Yet it also appears to be fairly common and is considered a frequent contributor to IBS, which is the most widespread gastrointestinal condition seen in clinical practice.
This 3-part webinar series, presented by Dr Jason Hawrelak, will discuss many of the controversies in the diagnosis and treatment of SIBO, as well as update you on recent research in this area.
– Is the Lactulose Breath Test really the most accurate breath test for diagnosing SIBO? Can other breath tests provide accurate diagnostic data?
– Is a strict diet necessary as a keystone of treatment?
– Are probiotics really contraindicated in the management of SIBO?
– Do prebiotics have any role to play in its treatment?
– What are effective herbal approaches in the management of the three main SIBO varieties – hydrogen, methane, and hydrogen-sulphide?
– How can we protect the colonic microbiome from damage, whilst still effectively eradicating SIBO?
These topics, and many more, will be covered over the course of this webinar series.
By the end of this course, you will have a refreshed understanding of SIBO and the practical applications of testing and therapeutic strategies from one of the leaders in this field.
The webinars will be recorded and available to watch at a time that suits you.
Live class dates: May 12th, 19th & 26th 11.30-13.00 UK GMT
4.5 hours CPD (BANT, NTOI, ANP)
Dr Jason Hawrelak
Dr Jason Hawrelak is a researcher, educator, naturopath and Western herbalist with over 20 years’ clinical experience. He did his PhD examining the capacity of probiotics, prebiotics and herbal medicines to modify the GIT microbiota and teaches extensively, both in Australia and internationally, on these topics. He is on the Medical Nutrition Council of the American Society for Nutrition and is a Fellow of both the American College of Nutrition and the Naturopaths and Herbalists Association of Australia. Dr Hawrelak is currently the Senior Lecturer in Complementary and Alternative Medicines at the University of Tasmania’s College of Health and Medicine (Hobart, Tasmania), where he coordinates the Evidence-based Complementary Medicine programs. He also teaches natural approaches to Gastroenterology within the University of Western States Master of Science in Human Nutrition and Functional Medicine program (Portland, Oregon). Dr Hawrelak is also Chief Research Officer at ProbioticAdvisor.com, which offers a searchable database that enables easy, evidence-based prescribing of probiotic products, as well as online resources for clinicians to learn more about the human microbiome and how they can positively influence these ecosystems.